433
Views
1
CrossRef citations to date
0
Altmetric
Methods and Method Development

In vitro megakaryocyte culture from human bone marrow aspirates as a research and diagnostic tool

ORCID Icon, , , , ORCID Icon &
Pages 928-935 | Received 23 May 2020, Accepted 24 Aug 2020, Published online: 16 Sep 2020
 

Abstract

Megakaryocytes (MKs) are relatively rare in bone marrow, comprising <0.05% of the nucleated cells, which makes direct isolation from human bone marrow impractical. As such, in vitro expansion of primary MKs from patient samples offers exciting fundamental and clinical opportunities. As most of the developed ex vivo methods require a substantial volume of biomaterial, they are not widely performed on young patients. Here we propose a simple, robust, and adapted method of primary human MK culture from 1 mL of bone marrow aspirate. Our technique uses a small volume of bone marrow per culture, uses straightforward isolation methods, and generates approximately 6 × 105 mature MKs per culture. The relative high cell purity and yield achieved by this technique, combined with efficient use of low volumes of bone marrow, make this approach suitable for diagnostic and basic research of human megakaryopoiesis.

Authorship Contribution

KRB performed experiments, analyzed data, worked with patients’ data, designed the research, and wrote the manuscript; EYO analyzed data and performed cell culture experiments; NBM performed cell culture experiments and light microscopy; NMT worked with patients, and performed bone marrow biopsies; MAP and KRM designed and supervised research, and wrote the manuscript.

Ethics Committee

The research was approved by the Center for Theoretical Problems of Physicochemical Pharmacology Ethics Committee. Prior to all collections, written informed consent was obtained from the parents.

Additional information

Funding

The work was supported by the grant from the endowment fund Doctors, Innovations, Science for Children to MAP. KRM is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK111515) at the National Institutes of Health and is an American Society of Hematology Scholar.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.